HUP9902682A2 - N-N-[N-(4-piperidin-4-il)-butanoil)-N-etil-glicil]-vegyületek nem higroszkópos, stabil, kristályos alakja, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyászati készítmények
- Google Patents
N-N-[N-(4-piperidin-4-il)-butanoil)-N-etil-glicil]-vegyületek nem higroszkópos, stabil, kristályos alakja, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyászati készítmények
Info
Publication number
HUP9902682A2
HUP9902682A2HU9902682AHUP9902682AHUP9902682A2HU P9902682 A2HUP9902682 A2HU P9902682A2HU 9902682 AHU9902682 AHU 9902682AHU P9902682 AHUP9902682 AHU P9902682AHU P9902682 A2HUP9902682 A2HU P9902682A2
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone-Poulenc Rorer Pharmaceuticals Inc.filedCriticalRhone-Poulenc Rorer Pharmaceuticals Inc.
Priority to HU9902682ApriorityCriticalpatent/HUP9902682A3/hu
Publication of HUP9902682A2publicationCriticalpatent/HUP9902682A2/hu
Publication of HUP9902682A3publicationCriticalpatent/HUP9902682A3/hu
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
A találmány az N-[N-[N-(4-piperidin-4-il)-bűtanőil)-N-etil-glicil]-(L)-aszpartil]-(L)--ciklőhexil-alanin-amid-származékők nemhigrőszkópős, stabil kristályős alakjára a kristályős alak előállításieljárásaira, ilyen vegyület kristályős alakját tartalmazó gyógyászatikészítményre, valamint e vegyület köztestermékeire vőnatkőzik. ŕ
HU9902682A1997-08-211997-08-21Stable non-hygroscopic crystalline form of n-n-[n-(4-piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds, process for producing them and pharmaceutical compositions containing them
HUP9902682A3
(en)
Stable non-hygroscopic crystalline form of n-n-[n-(4-piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds, process for producing them and pharmaceutical compositions containing them
Stable non-hygroscopic crystalline form of n-n-[n-(4-piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds, process for producing them and pharmaceutical compositions containing them
Stable non-hygroscopic crystalline form of n-n-[n-(4-piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds, process for producing them and pharmaceutical compositions containing them
Process for preparing of new n- aryl and n- heteroaryla-mide and urea derivatives as inhibitors of acyl coenzymes a: cholesterol acyl transferase ( A C A T )
Ny fremgangsmåte for fremstilling av amorft £R-(R*,R*)|-2-(4-fluorfenyl)-<beta>,<delta>-dihydroksy-5-(1-metyletyl)-3-fenyl-4-£(fenylamino)karbonyl|-1H-pyrrol-1-heptansyre-kalsiumsalt (2:1)
Phenylacetic acid derivatives, process and intermediates for producing them, fingicide, insecticide, arachnicide and nematocide compositions containing these compounds as active ingredients and use thereof
Crystalline 3,4,4-trisubstituted piperidinyl-N-(3-phenylprop-2-YL) carboxylic acid derivatives pharmaceutical compositions containing them and processes for their preparation
Processes for producing 7-isoindolinequinolonecarboxylic derivatives and intermediates therefor, salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and composition containing the same as active ingredient
Process for producing pharmaceutical compositions containing heptapeptide somatostatin derivatives of neurogene- and non-neurogene-antiflogistic and analgesic activity and peptidomimetica
Maleic acid salts of 3-(2-(4-(4-(amino-imino-methyl)-phenyl)-4-methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3-phenyl propionicacid ethylester, pharmaceutical compositons containing them and process for producing them
N-N-[N-(4-piperidin-4-il)-butanoil)-N-etil-glicil]-vegyületek nem higroszkópos, stabil, kristályos alakja, eljárás előállításukra és ezeket a vegyületeket tartalmazó gyógyászati készítmények
Process for producing 3-(l-pyroglutamyl)-l-thiazolidine-4-carboxylic aci derivatives and pharmaceutical compositions comprising such compounds as active ingredient
+/- 2-((3,4-methylenedioxy)phenethyl)-5-((3-carboxamido-4-hydroxy)-alpha-hydroxybenzyl)pyrrolidines, pharmaceutical compositions containing them, process for their production and intermediates therefor
Novel crystals of N-hydroxy-2(S)-methyl-5-ethoxymethoxy -4(S)-(N-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient